CASI Pharmaceuticals, Inc. (CASI) DCF Valuation

CASI Pharmaceuticals, Inc. (CASI) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

CASI Pharmaceuticals, Inc. (CASI) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our CASI (CASI) DCF Calculator empowers you to evaluate CASI Pharmaceuticals, Inc. valuation using actual financial data, providing complete flexibility to modify all essential parameters for improved projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 4.1 15.1 30.2 43.1 33.9 52.6 81.6 126.6 196.5 304.9
Revenue Growth, % 0 266.52 99.25 42.89 -21.41 55.18 55.18 55.18 55.18 55.18
EBITDA -37.4 -31.4 -32.7 -24.1 -21.5 -44.1 -68.4 -106.2 -164.8 -255.7
EBITDA, % -906.08 -207.08 -108.55 -55.84 -63.58 -83.88 -83.88 -83.88 -83.88 -83.88
Depreciation 2.2 3.2 3.1 2.4 3.7 10.6 16.4 25.4 39.4 61.2
Depreciation, % 52.12 21.34 10.26 5.62 11.04 20.08 20.08 20.08 20.08 20.08
EBIT -39.6 -34.6 -35.8 -26.5 -25.3 -45.9 -71.2 -110.4 -171.4 -265.9
EBIT, % -958.19 -228.42 -118.81 -61.45 -74.62 -87.21 -87.21 -87.21 -87.21 -87.21
Total Cash 54.2 66.4 48.6 51.3 30.8 51.6 80.1 124.3 192.9 299.3
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.3 4.6 9.8 13.0 10.1
Account Receivables, % 31.3 30.68 32.49 30.09 29.92
Inventories 4.5 1.4 1.9 6.1 15.9 18.5 28.8 44.7 69.3 107.6
Inventories, % 109.95 8.96 6.32 14.24 46.86 35.28 35.28 35.28 35.28 35.28
Accounts Payable 5.1 3.7 4.8 3.3 4.4 16.9 26.2 40.7 63.2 98.1
Accounts Payable, % 123.77 24.23 15.87 7.63 13.1 32.17 32.17 32.17 32.17 32.17
Capital Expenditure -14.0 -19.3 -15.5 -5.6 -2.2 -28.5 -44.2 -68.6 -106.5 -165.3
Capital Expenditure, % -339.39 -127.65 -51.38 -13.02 -6.61 -54.2 -54.2 -54.2 -54.2 -54.2
Tax Rate, % -2.46 -2.46 -2.46 -2.46 -2.46 -2.46 -2.46 -2.46 -2.46 -2.46
EBITAT -44.9 -45.5 -37.8 -27.9 -25.9 -45.9 -71.2 -110.4 -171.4 -265.9
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -57.4 -63.3 -54.8 -40.0 -30.2 -60.1 -108.9 -168.9 -262.2 -406.8
WACC, % 6.45 6.45 6.45 6.45 6.45 6.45 6.45 6.45 6.45 6.45
PV UFCF
SUM PV UFCF -794.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -415
Terminal Value -9,324
Present Terminal Value -6,821
Enterprise Value -7,615
Net Debt 4
Equity Value -7,619
Diluted Shares Outstanding, MM 13
Equity Value Per Share -570.31

What You Will Get

  • Real CASI Financials: Access to historical and projected data for precise valuation.
  • Adjustable Inputs: Customize WACC, tax rates, revenue growth, and capital expenditures.
  • Automatic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Evaluate various scenarios to assess CASI's future performance.
  • Clear and Intuitive Design: Designed for professionals but easy for beginners to navigate.

Key Features

  • Comprehensive CASI Data: Pre-filled with CASI Pharmaceuticals' historical performance metrics and future growth projections.
  • Customizable Financial Inputs: Modify revenue growth rates, profit margins, discount rates, tax assumptions, and capital investments.
  • Interactive Valuation Model: Real-time updates to Net Present Value (NPV) and intrinsic value based on user-defined parameters.
  • Flexible Scenario Analysis: Develop various forecasting scenarios to explore different valuation possibilities.
  • Intuitive User Interface: Clean, organized layout designed for both seasoned professionals and newcomers.

How It Works

  • Download: Obtain the ready-to-use Excel file featuring CASI Pharmaceuticals, Inc. (CASI) financial data.
  • Customize: Modify forecasts, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop multiple projections and instantly compare outcomes.
  • Make Decisions: Leverage the valuation results to inform your investment strategy.

Why Choose This Calculator for CASI Pharmaceuticals, Inc. (CASI)?

  • User-Friendly Interface: Tailored for both novices and seasoned professionals.
  • Customizable Inputs: Easily adjust parameters to suit your specific analysis.
  • Real-Time Adjustments: Observe immediate updates to CASI's valuation as you change inputs.
  • Pre-Loaded Data: Comes with CASI's actual financial metrics for swift evaluations.
  • Relied Upon by Experts: Utilized by investors and analysts for informed decision-making.

Who Should Use This Product?

  • Investors: Accurately estimate CASI Pharmaceuticals, Inc.'s (CASI) fair value before making investment decisions.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to CASI.
  • Consultants: Quickly tailor the template for valuation reports focused on CASI for clients.
  • Entrepreneurs: Gain insights into financial modeling techniques applied by leading pharmaceutical companies.
  • Educators: Employ it as a teaching resource to illustrate valuation methodologies in the pharmaceutical sector.

What the Template Contains

  • Historical Data: Includes CASI Pharmaceuticals, Inc.'s (CASI) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate CASI's intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of CASI's financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.